Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fenofibrate micronized is a lipid regulating agent that belongs to the class of medications known as fibrates. It is a peroxisome proliferator receptor alpha (PPARα) activator used to lower LDL cholesterol, total cholesterol, triglycerides, and apolipoprotein B, while increasing HDL cholesterol in patients with hypercholesterolemia, mixed dyslipidemia, and severe hypertriglyceridemia. The micronized formulation improves bioavailability compared to non-micronized fenofibrate. Fenofibrate is a pro-drug that is converted by ester hydrolysis in the body to fenofibric acid, which is the active constituent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fenofibrate micronized.